Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04085510
NA

Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania

Sponsor: Wendie Berg

View on ClinicalTrials.gov

Summary

This is a prospective clinical trial that will examine if contrast-enhanced mammography substantially improves breast cancer detection compared to mammography with tomosynthesis, with minimal increase in false-positives, in women with a personal history of breast cancer.

Official title: Improving Surveillance of Women With Personal History of Breast Cancer Using Contrast-Enhanced Mammography (CEM)

Key Details

Gender

FEMALE

Age Range

30 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

1647

Start Date

2019-10-23

Completion Date

2028-12-30

Last Updated

2026-03-09

Healthy Volunteers

Yes

Interventions

DEVICE

Contrast-enhanced mammogram

Contrast-enhanced mammography (CEM) is a new FDA-approved exam that is similar to magnetic resonance imaging (MRI) in depicting breast cancers due to increased and leaky blood vessels. Contrast-enhanced mammography is used as an adjunct following mammography and/or ultrasound examinations to localize a known or suspected lesion.

Locations (3)

Magee Womancare Passavant Cranberry

Cranberry Township, Pennsylvania, United States

Magee Womancare Monroeville

Monroeville, Pennsylvania, United States

Magee Womens Hospital

Pittsburgh, Pennsylvania, United States